Progressive vascular damage in hypertension is associated with increased levels of circulating P-selectin

Journal of Hypertension

Volumn 16, Issue 1, 1998, Pages 45-50

  Verhaar, Marianne C ^a,b   Beutler, Jaap J ^a   Gaillard, Carlo A ^b   Koomans, Hein A ^a   Fijnheer, Rob ^a   Rabelink, Ton J ^a,c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b EEMLAND HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Endothelial damage; Hypertension; Selectins; Soluble adhesion molecules; Von Willebrand factor

Indexed keywords

CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; PADGEM PROTEIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MALIGNANT HYPERTENSION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RENOVASCULAR HYPERTENSION; VASCULAR ENDOTHELIUM; VENOUS BLOOD;

EID: 0031892479     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816010-00008     Document Type: Article

References (33)

1. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335:765-774.
2. Stamler J, Neaton JD, Wentworth DN. Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease. Hypertension 1989; 13:12-112.
3. Flavahan NA, Vanhoutte PM. Endothelial cell signaling and endothelial dysfunction. Am J Hypertens 1995; 8 (suppl):28S-41S.
4. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362:801-809.
5. Gryglewski RJ, Botting RM, Vane JR. Mediators produced by the endothelial cell. Hypertension 1988; 12:530-548.
6. Linder L, Kiowski W, Buhler FR, Luscher TF. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation 1990; 81:1762-1767.
7. Panza JA, Quyymi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323:22-27.
8. Blann AD, Taberner DA. A reliable marker of endothelial cell dysfunction: does it exist? Br J Haematol 1995; 90:244-248.
9. Conlan MG, Folsom AR, Finch A, Davis CE, Sorlie P, Marcucci G, et al. Associations of factor VIII and von Willebrand factor with age. race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 1993; 70:380-385.
10. Adams DH, Shaw S. Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet 1994; 343:831-836.
11. Newman W, Beall LD, Carson CW, Hunder GG, Graben N, Randhawa ZI, et al. Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. J Immunol 1993; 150:644-654.
12. Katayama M, Handa M, Araki Y, Ambo H, Kawai Y, Watanabe K, et al. Soluble P-selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenia purpura and haemolytic uraemic syndrome. Br J Haematol 1993; 84:702-710.
13. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88:4651-4655.
14. Kurose I, Kubes P, Wolf R, Anderson DC, Paulson J, Miyasaka M, et al. Inhibition of nitric oxide production. Mechanisms of vascular albumin leakage. Circ Res 1993; 73:164-171.
15. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994; 344:793-795.
16. Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, et al. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 1993; 92:1866-1874.
17. Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991; 251:788-791.
18. Poston RN, Haskard DO, Coucher JR, Gall NP, Johnson Tidey RR. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol 1992; 140:665-673.
19. van der Wal AC, Das PK, Tigges AJ, Becker AE. Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am J Pathol 1992; 141:1427-1433.
20. O'Brien KD, Allen MD, McDonald TO, Chait A, Harlan JM, Fishbein D, et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 1993; 92:945-951.
21. Johnson Tidey RR, McGregor JL, Taylor PR, Poston RN. Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques. Coexpression with intercellular adhesion molecule-1. Am J Pathol 1994; 144:952-961.
22. Pigott R, Dillon LP, Hemingway IH, Gearing AJ, Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 1992; 187:584-589.
23. Gearing AJ, Hemingway I, Pigott R, Hughes J, Rees AJ, Cashman SJ. Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance. Ann N Y Acad Sci 1992; 667:324-331.
24. Fijnheer R, Frijns CJM, Korteweg J, Rommes H, Peters JH, Sixma JJ, et al. The origin of P-selectin as a circulating plasma protein. Thromb Haemost 1997; 77:1081-1085.
25. Kostelijk EH, Fijnheer R, Nieuwenhuis HK, Gouwerok CWN, de Korte D. Soluble P-selectin as parameter for platelet activation during storage. Thromb Haemost 1996; 76:1086-1089.
26. Hamer RJ, Koedam JA, Beeser Visser NH, Sixma JJ. Human factor VIII: purification from commercial factor VIII concentrate, characterization, identification and radiolabeling. Biochim Biophys Acta 1986; 873:356-366.
27. Blann AD, Naqvi T, Waite M, McCollum CN. von Willebrand factor and endothelial damage in essential hypertension. J Hum Hypertens 1993; 7:107-111.
28. Pedrinelli R, Giampietro O, Carmassi F, Melillo E, Dell'Omo G, Catapano G, et al., Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994; 344:14-18.
29. Blann AD, Tse W, Maxwell SJ, Waite MA. Increased levels of the soluble adhesion molecule E-selectin in essential hypertension. J Hypertens 1994; 12:925-928.
30. Lip GY, Blann AD, Zarifis J, Beevers M, Lip PL, Beevers DG. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? [preliminary report]. J Hypertens 1995; 13:1674-1678.
31. Cockcroft JR, Chowienczyk PJ, Benjamin N, Ritter JM. Preserved endothelium-dependent vasodilatation in patients with essential hypertension. N Engl J Med 1994; 330:1036-1040.
32. Blann AD, Dobrotova M, Kubisz P, McCollum CN. von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis. Thromb Haemost 1995; 74:626-630.
33. Erl W, Weber C, Wardermann C, Weber PC. α-Tocopheryl succinate inhibits monocytic cell adhesion to endothelial cells by suppressing NF-kappa B mobilization. Am J Physiol 1997; 273:H634-H640.